Replies to post #4272 on Generex Biotechnology Corp. (fka GNBTQ)

[hotelbar]

Maybe there stalling to lead investors on. Imo

[RoswellChamp]

I believe the rules of ASCO require the "embargo" of the final data pending the ASCO presentation, so don't blame Generex for that delay. It does mean that if you are a bull on GNBT you are going to have a long wait for any more bump from AE-37!! Unless they come up with a partner in the interim.....???

While we are waiting, an update on the status of Ora-lyn in India would be nice....;-)

[veeets]

Would rather ASCO presentations than a mediocre PR now. Everyone can have their own opinions. If results are great, presentations have the wow factor, it will up the price paid for a partnership. Not looking for pennies here unless they are 100's and in multiples.